FDA Issues and its FDA Data Integrity - 2017

MessageThis Webinar is over
Date Sep 1, 2017
Time 10:00 am
Cost $ 150.00
Many of the data integrity issues that plagued the US drug and biologics 
industry were eliminated by detailed regulations and stricter enforcement, but 
many of the problems have resurfaced in recent years among the multitude 
of foreign manufacturers whoare not familiar with US practices.

Areas Covered in the Session:
Important Regulations related to Data Integrity, including laws related to the 
effects of bad data
Guidance Documents related to Data Integrity
Requirements for Computerized Instrument Outputs
Definition of Data Integrity Terms
Importance of Audit Trails
Examples of Violations 483s taken from Warning Letters

Who Will Benefit:
Quality Control and Quality Assurance Workers
Regulatory Affairs Personnel
Product Development Workers
Personnel Planning Clinical Studies
Manufacturing Supervisors

Speaker Profile:
Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP 
BioTechnology LLC, a consulting firm that works in the areas covered by the 
GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years 
of experience in supervising quality control laboratories, including an animal 
testing facility, and in performing GLP and GMP audits of internal and external 
testing laboratories . Steve has participated in the development of drugs and 
biologicals through all phases of clinical research and final product production.

Event Cost & Details:
One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list